Market Closed -
Euronext Paris
11:35:12 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
349
EUR
|
+0.72%
|
|
-7.18%
|
-2.92%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
959.3
|
1,993
|
2,008
|
3,584
|
1,927
|
2,921
|
2,921
|
-
|
Enterprise Value (EV)
1 |
1,385
|
2,361
|
1,917
|
3,510
|
1,848
|
2,983
|
2,995
|
2,877
|
P/E ratio
|
47.6
x
|
38.7
x
|
14.6
x
|
31.7
x
|
15.8
x
|
25
x
|
21.1
x
|
19
x
|
Yield
|
-
|
-
|
0.32%
|
0.29%
|
0.58%
|
0.37%
|
0.42%
|
0.47%
|
Capitalization / Revenue
|
1.1
x
|
2.12
x
|
2.15
x
|
3.37
x
|
1.58
x
|
2.43
x
|
2.12
x
|
1.97
x
|
EV / Revenue
|
1.59
x
|
2.52
x
|
2.05
x
|
3.3
x
|
1.52
x
|
2.39
x
|
2.17
x
|
1.94
x
|
EV / EBITDA
|
12
x
|
14.6
x
|
11.3
x
|
16.3
x
|
8.27
x
|
12.8
x
|
11.5
x
|
9.92
x
|
EV / FCF
|
40.3
x
|
21.7
x
|
21.3
x
|
36.5
x
|
40.7
x
|
50.8
x
|
34.3
x
|
25.6
x
|
FCF Yield
|
2.48%
|
4.6%
|
4.69%
|
2.74%
|
2.46%
|
1.97%
|
2.91%
|
3.91%
|
Price to Book
|
2.08
x
|
3.85
x
|
3.22
x
|
4.95
x
|
2.29
x
|
3.34
x
|
2.83
x
|
2.42
x
|
Nbr of stocks (in thousands)
|
8,430
|
8,427
|
8,436
|
8,443
|
8,451
|
8,370
|
8,370
|
-
|
Reference price
2 |
113.8
|
236.5
|
238.0
|
424.5
|
228.0
|
349.0
|
349.0
|
349.0
|
Announcement Date
|
3/18/19
|
3/16/20
|
3/17/21
|
3/22/22
|
3/23/23
|
3/19/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
868.8
|
938.3
|
934.2
|
1,064
|
1,216
|
1,247
|
1,378
|
1,480
|
EBITDA
1 |
115.8
|
162.1
|
169.1
|
215.1
|
223.4
|
232.8
|
261.1
|
290.2
|
EBIT
1 |
73
|
107.4
|
120.5
|
168.9
|
182.8
|
184.9
|
201.9
|
226.9
|
Operating Margin
|
8.4%
|
11.45%
|
12.9%
|
15.87%
|
15.03%
|
14.83%
|
14.65%
|
15.33%
|
Earnings before Tax (EBT)
1 |
40.89
|
77.67
|
175.2
|
159.1
|
176.4
|
174.2
|
194.6
|
220.2
|
Net income
1 |
20.1
|
51.6
|
137.5
|
113.2
|
122
|
121.3
|
138.8
|
154.9
|
Net margin
|
2.31%
|
5.5%
|
14.72%
|
10.64%
|
10.03%
|
9.73%
|
10.07%
|
10.47%
|
EPS
2 |
2.390
|
6.110
|
16.29
|
13.40
|
14.43
|
14.38
|
16.56
|
18.33
|
Free Cash Flow
1 |
34.4
|
108.6
|
89.92
|
96.25
|
45.41
|
58.74
|
87.28
|
112.4
|
FCF margin
|
3.96%
|
11.58%
|
9.63%
|
9.05%
|
3.73%
|
4.71%
|
6.33%
|
7.59%
|
FCF Conversion (EBITDA)
|
29.7%
|
67.02%
|
53.17%
|
44.76%
|
20.33%
|
25.23%
|
33.43%
|
38.72%
|
FCF Conversion (Net income)
|
171.14%
|
210.5%
|
65.4%
|
85.03%
|
37.22%
|
48.43%
|
62.87%
|
72.52%
|
Dividend per Share
2 |
-
|
-
|
0.7500
|
1.250
|
1.320
|
1.320
|
1.459
|
1.626
|
Announcement Date
|
3/18/19
|
3/16/20
|
3/17/21
|
3/22/22
|
3/23/23
|
3/19/24
|
-
|
-
|
Fiscal Period: December |
2019 S1
|
2019 S2
|
2020 S1
|
2021 Q1
|
2021 Q2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
---|
Net sales
1 |
463.6
|
-
|
478.3
|
266.5
|
262.9
|
529.4
|
288.2
|
246.4
|
318
|
298.4
|
616.4
|
304.9
|
295.2
|
609.9
|
314.8
|
316.4
|
341
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
50
|
48
|
79.1
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
115.5
|
-
|
-
|
108.5
|
-
|
-
|
-
|
Operating Margin
|
10.79%
|
-
|
16.54%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
18.74%
|
-
|
-
|
17.79%
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
-
|
3/16/20
|
7/20/20
|
4/15/21
|
9/22/21
|
-
|
10/18/21
|
3/22/22
|
6/15/22
|
9/15/22
|
9/15/22
|
10/18/22
|
9/19/23
|
-
|
10/23/23
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
426
|
368
|
-
|
-
|
-
|
-
|
73.5
|
-
|
Net Cash position
1 |
-
|
-
|
90.2
|
73.8
|
79.4
|
52.4
|
-
|
44
|
Leverage (Debt/EBITDA)
|
3.679
x
|
2.273
x
|
-
|
-
|
-
|
-
|
0.2817
x
|
-
|
Free Cash Flow
1 |
34.4
|
109
|
89.9
|
96.3
|
45.4
|
58.7
|
87.3
|
112
|
ROE (net income / shareholders' equity)
|
4.48%
|
10.5%
|
24.1%
|
16.8%
|
15.6%
|
13.9%
|
13.6%
|
13.5%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
9.62%
|
8.7%
|
9%
|
9%
|
Assets
1 |
-
|
-
|
-
|
-
|
1,268
|
1,395
|
1,542
|
1,721
|
Book Value Per Share
2 |
54.70
|
61.40
|
73.80
|
85.80
|
99.40
|
108.0
|
123.0
|
144.0
|
Cash Flow per Share
2 |
8.110
|
15.60
|
14.30
|
15.40
|
11.70
|
14.10
|
22.60
|
25.40
|
Capex
1 |
33.9
|
23
|
31
|
33.7
|
53.6
|
59.9
|
89.6
|
79.9
|
Capex / Sales
|
3.9%
|
2.45%
|
3.32%
|
3.16%
|
4.41%
|
4.8%
|
6.5%
|
5.4%
|
Announcement Date
|
3/18/19
|
3/16/20
|
3/17/21
|
3/22/22
|
3/23/23
|
3/19/24
|
-
|
-
|
Average target price
368
EUR Spread / Average Target +5.44% Consensus |
1st Jan change
|
Capi.
|
---|
| -2.92% | 3.12B | | -19.73% | 72.39B | | -11.01% | 6.54B | | +15.88% | 3.43B | | -0.68% | 1.4B | | -17.27% | 1.34B | | -2.73% | 1.26B | | -14.67% | 1.12B | | -5.37% | 990M | | -24.06% | 805M |
Veterinary Drugs
|